Better Marijuana Stock: Tilray vs. CannTrust Holdings

Which stock wins in a matchup between these two Canadian marijuana producers?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This article was originally published on Fool.com

There’s good news and bad news when it comes to Tilray (NASDAQ:TLRY) and CannTrust Holdings (NASDAQOTH:CNTTF). First, the bad news: Both Canadian marijuana stocks have tanked over the last couple of weeks. The good news, though, is that Tilray and CannTrust are still up a lot so far in 2018.

Tilray has been the bigger winner by far. But which of these two marijuana stocks is the better pick now? Here’s how Tilray and CannTrust compare.

Red Canadian maple leaf surrounded by marijuana leaves.

IMAGE SOURCE: GETTY IMAGES.

The case for Tilray

Tilray’s CEO, Brendan Kennedy, recently stated that there will be multiple $100 billion companies in the cannabis industry. And he thinks that Tilray will be one of them. If Tilray gets even close to achieving Kennedy’s prediction, the stock is a great pick right now.

Canada’s launch of its recreational marijuana market is a start. Tilray should have 912,000 square feet of growing space by the end of this year, with roughly three-quarters of that space in Canada. The company also has plenty of space available for future expansion. My colleague Sean Williams projects that Tilray will rank fourth among marijuana growers in total production capacity by 2020. I suspect that Sean’s prediction will prove to be on target.

While capacity is key, there’s something just as important for Tilray in the Canadian recreational market: supply agreements with provinces and territories. The company is in good shape on that front as well. Tilray claims supply agreements with eight Canadian provinces and territories. 

We can’t forget Canada’s medical marijuana market. Tilray is a major player in the space. The company signed a deal earlier this year with Sandoz Canada, a subsidiary of Novartis, to co-develop and co-market medical cannabis products. 

Tilray can’t achieve Kennedy’s vision by focusing just on Canada, though. And it isn’t. The company has a significant presence in Germany and is currently the only producer authorized to supply both cannabis flower and cannabis oils in the country. Tilray also is positioned to benefit from the growth of medical marijuana markets in other areas across the world, particularly Australia, the United Kingdom, and Latin America.

The case for CannTrust

CannTrust Holdings is a lot further away from a $100 billion market cap than Tilray is. But that could be viewed as a positive for the company.

Despite being smaller than Tilray in terms of market cap, CannTrust compares really well when it comes to production capacity. The company opened its 450,000-square-foot Niagara Perpetual Harvest Facility on June 26, 2018. CannTrust is also adding another 600,000 square feet of growing space that is fully funded. When the project is completed, the company anticipates annual production capacity topping 100,000 kilograms. 

CannTrust also has supply agreements lined up for the Canadian recreational marijuana market with nine provinces. It most recently locked up deals with the Atlantic provinces of Nova ScotiaNew BrunswickPrince Edward Island, and Newfoundland and Labrador. 

The company partnered with Kindred, a wholly owned subsidiary of Breakthru Beverage Group, to market cannabis products for the Canadian recreational market. Breakthru Beverage Group is a leading alcohol wholesaler in the U.S. and ranks as the largest alcoholic beverage broker in Canada. 

CannTrust hasn’t cracked the German medical marijuana market yet, but it is currently the only cannabis producer authorized to export to Denmark. The company has also exported medical cannabis to Australia. CannTrust has even launched a product in the U.S. — Brewbudz, a single-serve brew combining coffee with cannabis. 

Better marijuana stock

In my view, it’s an easy decision between Tilray and CannTrust. Maybe someday Tilray will become a $100 billion company, but I don’t think it deserves to even be a $10 billion company right now.

Unlike Tilray, CannTrust is already profitable. And with a market cap below $850 million, it’s arguably one of the cheapest Canadian marijuana stocks on the market. Tilray claims advantages in production capacity and in the German market, but I don’t think those are worth the stock trading at over 10 times higher than CannTrust does.

CannTrust faces risks, for sure, including the potential of a supply glut in Canada within a few years. For now, though, I see it as one of the better picks in the Canadian cannabis industry. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends CannTrust Holdings Inc. The Motley Fool has a disclosure policy.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »